From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 50s
AbbVie Q3 2026 Earnings Preview
Wall Street expects AbbVie to beat earnings estimates with $3.78 per share on October 30.
In brief
Wall Street expects AbbVie to beat earnings estimates with $3.78 per share on October 30. AbbVie reports Q3 2026 earnings on October 30 with $3.78 per share, a 103.2% year-over-year earnings growth. Originally reported by Alphastreet - Earnings Decoded. Market Intelligence Delivered.
Wall Street Expectations
Wall Street expects AbbVie to deliver strong growth in Q3 2026 results on October 30.
Consensus Estimates
21 analysts estimate $3.78 per share on $17.35B revenue for Q3 2026 results.
Recent Estimate Revisions
Consensus EPS estimate dropped 1.6% over 30 days from $3.84 to $3.78.
Year-Over-Year Growth
Earnings grew 103.2% year-over-year to $3.78 from $1.86 in Q3 2025.
What to Watch
Focus on management's explanation for improved net profitability versus 1.2% margin last year.
The main idea
AbbVie reports Q3 2026 earnings on October 30 with $3.78 per share, a 103.2% year-over-year earnings growth.
